Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
added benefit for melanoma with BRAF V600 mutation
.
Show all posts
Showing posts with label
added benefit for melanoma with BRAF V600 mutation
.
Show all posts
Monday, December 19, 2016
Cobimetinib combined with vemurafenib shows added benefit for melanoma with BRAF V600 mutation
›
In continuation of my update on Cobimetinib and Vemurafenib Cobimetinib (trade name: Cotellic) has been approved since November 20...
›
Home
View web version
